WINDBER, PA (October 30, 2006)— Applied Computational Technologies, LLC (AppCompTech) has announced that it is receiving investment funding from Ben Franklin Technology Partners and Pittsburgh Life Sciences Greenhouse (PLSG). Both organizations are investing $100,000 into AppCompTech for an infusion of new capital totaling $200,000.

“This funding comes at a very critical time in our company’s development,” said Jay McClatchey, managing partner of AppCompTech. “We are in the home stretch of and making final preparations for the long-awaited release of our product into the market. This funding will help ensure that this critical technology finds its way into the hands of physicians as quickly as possible.”

Ben Franklin awarded the endowment through its Challenge Investment Program. To win the award, AppCompTech presented a course of development for its product – ProACTive – for the next year in competition with a number of companies in Ben Franklin’s 34-county region.

This marks the first time AppCompTech has received investment funding from Ben Franklin. AppCompTech previously received a $35,000 grant from Ben Franklin after winning its Big Idea Business Plan Contest last summer.

“We were very pleased with how far they’ve gone and how well they’ve worked on this fairly long-range project with very little funding to date,” said John Johnstown of Ben Franklin. “We felt they were very worthy of getting Ben Franklin’s help.”

The PLSG award is the second $100,000 investment it has made into AppCompTech. John Manzetti, chief operating officer of PLSG, said his organization views ProACTive as a revolutionary product that will greatly improve treatment for cancer patients and help more people beat the disease.

“We think it’s a strong position for them to be the first into the market with this technology,” Manzetti said. “We are hoping through this investment that they can become a more successful and viable operation.”

About AppCompTech
Applied Computational Technologies, LLC (AppCompTech) is a high-tech software development company formed around its premiere product, ProACTive™. ProACTive™ is a broad-based, patent-pending Particle Transport Simulation technology that is valuable in multiple markets from life sciences to nuclear power. 

AppCompTech’s primary focus is developing ProACTive™ into a high-performance radiation treatment planning tool for cancer therapy. In 2006, an estimated 1.4 million Americans will be diagnosed with cancer and approximately 65% of those cancer victims will receive some form of radiation therapy. ProACTive™ will benefit thousands of cancer patients annually by significantly improving a radiation oncologist’s planning capability, leading to better treatment outcomes and reduced side effects. 

About Ben Franklin Technology Partners
Ben Franklin Technology Partners is a statewide network that fosters innovation to stimulate Pennsylvania's economic growth and prosperity. Operating regionally with four centers strategically located throughout the Commonwealth, Ben Franklin Technology Partners brings together the best of Pennsylvania's people, ideas, and technology to serve as a catalyst for advancing the state's knowledge-based economy.

About Pittsburgh Life Sciences Greenhouse
The Pittsburgh Life Sciences Greenhouse is a public/private partnership, founded by the University of Pittsburgh, Carnegie Mellon University, UPMC Health System, the Commonwealth of Pennsylvania and its regional foundation community. Together with private industry and advanced research and healthcare capabilities of our institutional partners, PLSG invests in and supports the growth of regional life sciences companies in the areas of: bioinformatics; bionanotechnology; diagnostics; medical devices; medical robotics; therapeutics; and tools and services.

For more information on Applied Computational Technologies, visit www.appcomptech.com.

# # #